Grading of recommendations, assessment, development, and evaluation (GRADE): Pfizer-BioNTech COVID-19 vaccine for persons aged 12-15 years; 2021 May 14
Source: Centers for Disease Control and Prevention
Reference to “Grading of recommendations, assessment, development, and evaluation (GRADE): Pfizer-BioNTech COVID-19 vaccine for persons aged 12-15 years” does not constitute endorsement or recommendation by the U.S. Government, Department of Health and Human Services, or Centers for Disease Control and Prevention. The material may otherwise be available on the agency website for no charge.